Resistance of Candida albicans to azole antifungal agents.
Hitchcock
C A
CA
Department of Discovery Biology, Pfizer Central Research, Sandwich, Kent, U.K.
D000935:Antifungal Agents / Q000378:metabolism / Q000633:toxicity*; D001393:Azoles / Q000378:metabolism / Q000633:toxicity*; D002176:Candida albicans / Q000187:drug effects* / Q000302:isolation & purification / Q000378:metabolism*; D002463:Cell Membrane Permeability; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism*; D004352:Drug Resistance, Microbial / Q000502:physiology*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000382:microbiology; D010088:Oxidoreductases / Q000378:metabolism
D000935:Antifungal Agents; D001393:Azoles; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; C039306:sterol delta-5 desaturase